Viewing Study NCT05315557


Ignite Creation Date: 2025-12-24 @ 6:59 PM
Ignite Modification Date: 2026-02-28 @ 4:57 AM
Study NCT ID: NCT05315557
Status: UNKNOWN
Last Update Posted: 2022-04-07
First Post: 2022-03-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Vasopressin Versus Terlipressin as a Second Vasopressor in Critically Ill Cirrhotics With Septic Shock- the VITEL-C Trial
Sponsor: Institute of Liver and Biliary Sciences, India
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Septic Shock View
None Cirrhosis, Liver View
Keywords: